Kent Catalysis submits IPO registration to the Shanghai Stock Exchange, focusing on the field of phase-transfer catalysts.

On January 13th, Kent Catalyst Materials Co., Ltd. (referred to as Kent Catalyst) applied for a status change in the IPO review on the Shanghai Stock Exchange Main Board to "submit registration". Sinolink is its sponsoring institution, planning to raise 499 million yuan. According to the prospectus, Kent Catalyst is a high-tech enterprise mainly engaged in the research, production, and sales of quaternary ammonium compound products, with four major series of products including quaternary ammonium salt, quaternary ammonium base, quaternary ammonium salt, and crown ether. It is committed to providing high-quality products and services for customers in the fields of fine chemicals, molecular sieves, polymer materials, battery electrolytes, and oilfield chemicals. Phase transfer catalysts are catalysts that can help reactants transfer from one phase to another where the reaction can occur, thereby accelerating the reaction rate of heterogeneous systems. Quaternary ammonium salts, quaternary ammonium bases, quaternary ammonium salts, crown ethers, tertiary amines, and polyethers can all serve as phase transfer catalysts. Through years of technological research and innovation and industrial applications, Kent Catalyst has accumulated a significant amount of technological and product advantages in the field of phase transfer catalysts in China. By continuously expanding its application areas, products like quaternary ammonium compounds have been extended from initial phase transfer catalysts to molecular sieve template agents, curing promoters, electrolyte additives, and are widely used in fine chemicals, molecular sieves, polymer materials, battery electrolytes, oilfield chemicals, and other fields. With outstanding and stable product quality and good market reputation, the company's products are widely recognized in the market. Currently, the company has established good cooperative relationships with many well-known enterprises in the pharmaceutical, molecular sieve, and chemical industries such as Luxi Catalyst Co., Ltd., China Catalyst Holding, Zhejiang Huahai Pharmaceutical, Wanhua Chemical Group, Valiant Co., Ltd., Zhejiang Yongtai Technology Co., and Tianjin Tianchen Green Energy Engineering Technology Development Co. The funds raised from this public offering will be used for the following purposes: In terms of finances, in fiscal year 2021, 2022, 2023, and January to June 2024, Kent Catalyst achieved operating incomes of approximately 636 million yuan, 808 million yuan, 666 million yuan, and 298 million yuan, respectively. During the same period, the company realized net profits of approximately 86.33 million yuan, 110 million yuan, 85.21 million yuan, and 40.04 million yuan respectively.